Table of Contents
Tables 5-61: Parke
Tables 5-63: Pike
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 1999 | 1995 - 1999 | 1999 | 1995 - 1999 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All sites | 36 | 393.6 | 197 | 436.6 | 27 | 297.6 | 108 | 244.6 |
| Esophagus | * | # | 6 | 13.6** | * | # | 3 | # |
| Stomach | * | # | 5 | 10.1** | * | # | 3 | # |
| Colon excluding Rectum | 5 | 55.6** | 22 | 48.6 | 5 | 52.3** | 17 | 37.3** |
| Rectum and Rectosigmoid Junction | * | # | 12 | 25.8** | * | # | 0 | # |
| Liver | * | # | 2 | # | * | # | 3 | # |
| Pancreas | * | # | 3 | # | * | # | 4 | # |
| Lung and Bronchus | 5 | 52.7** | 35 | 77.2 | 7 | 72.3** | 33 | 71.7 |
| Melanoma of the Skin | * | # | 5 | 11.1** | * | # | 1 | # |
| Prostate | 11 | 126.2** | 44 | 98.4 | * | # | 7 | 18.3** |
| Urinary Bladder | * | # | 9 | 20.5** | * | # | 4 | # |
| Kidney and Renal Pelvis | * | # | 4 | # | * | # | 3 | # |
| Brain | * | # | 5 | 10.5** | * | # | 4 | # |
| Non-Hodgkins Lymphoma | * | # | 5 | 10.6** | * | # | 6 | 14.4** |
| Myeloma | * | # | 3 | # | * | # | 2 | # |
| Leukemia | * | # | 6 | 15.2** | * | # | 2 | # |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 1999 | 1995 - 1999 | 1999 | 1995 - 1999 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All sites | 48 | 412.1 | 222 | 394.5 | 20 | 169.5 | 99 | 169.8 |
| Colon excluding Rectum | 5 | 38.4** | 29 | 48.5 | * | # | 12 | 19.5** |
| Rectum and Rectosigmoid Junction | * | # | 6 | 11.1** | * | # | 2 | # |
| Liver | * | # | 2 | # | * | # | 1 | # |
| Pancreas | * | # | 5 | 7.5** | * | # | 2 | # |
| Lung and Bronchus | 7 | 59.1** | 33 | 60.7 | * | # | 25 | 43.4 |
| Melanoma of the Skin | * | # | 9 | 19.4** | * | # | 2 | # |
| Breast | 13 | 109.3** | 62 | 110.2 | * | # | 16 | 27.8** |
| Cervix Uteri | * | # | 5 | 10.2** | * | # | 2 | # |
| Corpus Uteri | * | # | 13 | 23.1** | * | # | 1 | # |
| Ovary | * | # | 6 | 10.5** | * | # | 4 | # |
| Urinary Bladder | * | # | 5 | 7.6** | * | # | 0 | # |
| Kidney and Renal Pelvis | * | # | 4 | # | * | # | 0 | # |
| Brain | * | # | 1 | # | * | # | 1 | # |
| Non-Hodgkins Lymphoma | * | # | 6 | 10.3** | * | # | 3 | # |
| Myeloma | * | # | 1 | # | * | # | 4 | # |
| Leukemia | * | # | 6 | 10.5** | * | # | 6 | 8.9** |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, March 2003